§ 109395 Cancer Drug Reconsideration

Health and Safety Code·California

AI SummaryVerified

This law says that if new information or evidence comes up, the government can take another look at a drug or treatment for cancer that was previously rejected.

Key Takeaways

•If a cancer drug was rejected before, it can be reviewed again if there's new evidence.
•The new review must follow the rules and use new data that wasn't available before.
•This only applies to drugs, treatments, or devices for cancer.

Example

A company had a cancer drug that was rejected before, but now they have new research showing it works better.

The government can review the drug again because of the new research.

AI-generated — May contain errors. Not legal advice. Always verify source.

Official Source

View on CA.gov

§ 109395 Cancer Drug Reconsideration

No provision of this article and Article 1 (commencing with Section 109250) shall preclude reconsideration of an application for use of any drug, medicine, compound or device for the diagnosis, treatment, alleviation or cure of cancer if new evidence or matter is presented to the department and the reconsideration is predicated upon compliance with the applicable sections of the law, and presentation of data developed subsequent to the applicable ruling of the board. (Added by Stats. 1995, Ch. 415, Sec. 6. Effective January 1, 1996.)

Last verified: January 11, 2026

Key Terms

reconsideration application drug medicine compound device diagnosis treatment alleviation cure cancer new evidence department applicable sections of the law data developed subsequent to the applicable ruling of the board

References

Official text at leginfo.legislature.ca.gov
California Legislature. Health and Safety Code. Section 109395.

Key Takeaways

Example

Key Terms

Related Statutes

References

Key Takeaways

Example

Key Terms

Related Statutes

References